Literature DB >> 14660639

Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.

Richard H Ho1, Brenda F Leake, Richard L Roberts, Wooin Lee, Richard B Kim.   

Abstract

The key transporter responsible for hepatic uptake of bile acids from portal circulation is Na+-taurocholate cotransporting polypeptide (NTCP, SLC10A1). This transporter is thought to be critical for the maintenance of enterohepatic recirculation of bile acids and hepatocyte function. Therefore, functionally relevant polymorphisms in this transporter would be predicted to have an important impact on bile acid homeostasis/liver function. However, little is known regarding genetic heterogeneity in NTCP. In this study, we demonstrate the presence of multiple single nucleotide polymorphisms in NTCP in populations of European, African, Chinese, and Hispanic Americans. Specifically four nonsynonymous single nucleotide polymorphisms associated with a significant loss of transport function were identified. Cell surface biotinylation experiments indicated that the altered transport activity of T668C (Ile223-->Thr), a variant seen only in African Americans, was due at least in part to decreased plasma membrane expression. Similar expression patterns were observed when the variant alleles were expressed in HepG2 cells, and plasma membrane expression was assessed using immunofluorescence confocal microscopy. Interestingly the C800T (Ser267-->Phe) variant, seen only in Chinese Americans, exhibited a near complete loss of function for bile acid uptake yet fully normal transport function for the non-bile acid substrate estrone sulfate, suggesting this position may be part of a region in the transporter critical and specific for bile acid substrate recognition. Accordingly, our study indicates functionally important polymorphisms in NTCP exist and that the likelihood of being carriers of such polymorphisms is dependent on ethnicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660639     DOI: 10.1074/jbc.M305782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.

Authors:  Shadi Abu-Hayyeh; Pablo Martinez-Becerra; Siti H Sheikh Abdul Kadir; Clare Selden; Marta R Romero; Myrddin Rees; Hanns-Ulrich Marschall; Jose J G Marin; Catherine Williamson
Journal:  J Biol Chem       Date:  2010-02-20       Impact factor: 5.157

2.  Deleterious nonsynonymous single nucleotide polymorphisms in human solute carriers: the first comparison of three prediction methods.

Authors:  Da-Cheng Hao; Bing Xiao; Ying Xiang; Xue-Wei Dong; Pei-Gen Xiao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-05-04       Impact factor: 2.441

3.  Optimization and Application of a Biotinylation Method for Quantification of Plasma Membrane Expression of Transporters in Cells.

Authors:  Vineet Kumar; Tot Bui Nguyen; Beáta Tóth; Viktoria Juhasz; Jashvant D Unadkat
Journal:  AAPS J       Date:  2017-07-24       Impact factor: 4.009

4.  NTCP deficiency and persistently raised bile salts: an adult case.

Authors:  Filip Van Herpe; Hans R Waterham; Christopher J Adams; Marcel Mannens; Hennie Bikker; Frédéric M Vaz; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2017-03-10       Impact factor: 4.982

Review 5.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

6.  Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability.

Authors:  Richard H Ho; Brenda F Leake; Dawn M Kilkenny; Henriette E Meyer Zu Schwabedissen; Hartmut Glaeser; Deanna L Kroetz; Richard B Kim
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

Review 7.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

8.  The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.

Authors:  Ping An; Zheng Zeng; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

9.  Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites.

Authors:  Brandon Swift; Noelia Nebot; Jin Kyung Lee; Tianxiang Han; William R Proctor; Dhiren R Thakker; Dieter Lang; Martin Radtke; Mark J Gnoth; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-03-12       Impact factor: 3.922

10.  Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defect.

Authors:  Saul J Karpen; Paul A Dawson
Journal:  Hepatology       Date:  2014-11-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.